Guoxin Health released its 2026 interim report. Total operating revenue was 102 million yuan, up 6.30% year-on-year, but net profit attributable to the parent company was negative 102 million yuan, with the loss widening year-on-year, down 3.1783 million yuan compared with the same period last year. Net cash flow from operating activities was negative 137 million yuan, down 17.1598 million yuan year-on-year. The company's asset-liability ratio was 32.98%, gross margin was negative 14.57%, return on equity was negative 9.15%, and diluted earnings per share was negative 0.10 yuan. The number of shareholders was 59,200, and the top ten shareholders held 31.78% of the total share capital.
China Reform Health Management and Services Group Co LtdNet loss widened year-on-year with negative operating cash flow and gross margin.
